Avian Influenza Virus Type A H7N7 subtype NP antibody and antigen (recombinant protein)
Diagnostic anti-Avian Influenza Virus Type A H7N7 subtype NP antibodies pairs and antigen for animal health (animal Avian/Bird/Poultry infectious disease ) testing in ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT
Go to Neurodegenerative diseases diagnostics products collection >>
Product information
Catalog No. | Description | US $ Price (per mg) |
---|---|---|
GMP-VT-P188-Tg001-Ag01 | Recombinant Avian Influenza Virus Type A H7N7 subtype NP protein | 3090 |
GMP-VT-P188-Tg001-Ab01 | Anti-Avian Influenza Virus Type A H7N7 subtype NP mouse monoclonal antibody (mAb) | 1953 |
GMP-VT-P188-Tg001-Ab02 | Anti-Avian Influenza Virus Type A H7N7 subtype NP mouse monoclonal antibody (mAb) | 1953 |
GMP-VT-P188-Tg001-Ab03 | Anti-Avian Influenza Virus Type A H7N7 subtype NP human monoclonal antibody (mAb) | 1953 |
GMP-VT-P188-Tg001-Ab04 | Anti-Avian Influenza Virus Type A H7N7 subtype NP human monoclonal antibody (mAb) | 1953 |
Size: 1mg | 10mg | 100mg
Product Description
Cat No. of Products | GMP-VT-P188-Tg001-Ag01 |
Product Name | Recombinant Avian Influenza Virus Type A H7N7 subtype NP protein |
Pathogen | Escherichia Coli F41 (E.coli F41) |
Target/Biomarker | NP |
Expression platform | E.coli |
Isotypes | Recombinant Antigen |
Bioactivity validation | Anti-Escherichia Coli F41 (E.coli F41) NP antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in Escherichia Coli F41 (E.coli F41) level test of animal Avian/Bird/Poultry with Avian Influenza Virus Type A H7N7 subtype infection. |
Tag | His |
Products description | Recombinant Avian Influenza Virus Type A H7N7 subtype NP protein was expressed in E.coli - based prokaryotic cell expression system and is expressed with 6 HIS tag at the C-terminus. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Cat No. of Products | GMP-VT-P188-Tg001-Ab01, GMP-VT-P188-Tg001-Ab02 |
Product Name | Anti-Avian Influenza Virus Type A H7N7 subtype NP mouse monoclonal antibody (mAb) |
Pathogen | Escherichia Coli F41 (E.coli F41) |
Target/Biomarker | NP |
Expression platform | CHO |
Isotypes | Mouse IgG |
Bioactivity validation | Recombinant Escherichia Coli F41 (E.coli F41) NP antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Escherichia Coli F41 (E.coli F41) antibodies in Escherichia Coli F41 (E.coli F41) level test of animal Avian/Bird/Poultry with Avian Influenza Virus Type A H7N7 subtype infection. |
Tag | mFc |
Products description | Anti-Avian Influenza Virus Type A H7N7 subtype NP mouse monoclonal antibody (mAb) is a monoclonal antibody produced by CHO. The antibody is ELISA validated as capture antibody and detection antibody pair. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Cat No. of Products | GMP-VT-P188-Tg001-Ab03, GMP-VT-P188-Tg001-Ab04 |
Product Name | Anti-Avian Influenza Virus Type A H7N7 subtype NP human monoclonal antibody (mAb) |
Pathogen | Escherichia Coli F41 (E.coli F41) |
Target/Biomarker | NP |
Expression platform | CHO |
Isotypes | Human IgG1 |
Bioactivity validation | Recombinant Escherichia Coli F41 (E.coli F41) NP antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Escherichia Coli F41 (E.coli F41) antibodies in Escherichia Coli F41 (E.coli F41) level test of animal Avian/Bird/Poultry with Avian Influenza Virus Type A H7N7 subtype infection. |
Tag | hFc |
Products description | Anti-Avian Influenza Virus Type A H7N7 subtype NP human monoclonal antibody (mAb) is a monoclonal antibody produced by CHO. The antibody is ELISA validated as capture antibody and detection antibody pair. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Validation Data
Click to get more Data / Case study about the product.
Target/Biomarker information
he spread of highly pathogenic avian influenza (HPAI) viruses of H5 or H7 subtypes and low pathogenic avian influenza (LPAI) viruses of H5, H7 or H9 subtypes amongst birds and sporadic infection in humans continues to pose a threat to public health. In 2003, 89 people were confirmed as being infected with HPAI H7N7 in the Netherlands with evidence of limited person to person transmission, which was associated with an outbreak of HPAI H7N7 in chickens in over 200 farms [4], [5]. In 2007, four cases infected with LPAI H7N2 were identified after an outbreak of LPAI H7N2 in chickens on a small farm in north Wales in the United Kingdom [6].
About GDU
GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.
Comments
No comments yet.